Ketogenic Research | Keto-Mojo

Cancer
Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma

Pediatric high-grade gliomas (HGGs) are aggressive brain tumors with poor outcomes and substantial treatment-related toxicity. Because glioma cells rely heavily on glucose and glutamine metabolism,...
Cancer, Neurology
Intensive Multimodal Ketogenic Metabolic Therapy in Glioblastoma: A Clinical Trial

Glioblastoma (GBM), isocitrate dehydrogenase (IDH)-wildtype, is the most common and aggressive primary brain tumor in adults, with a median overall survival of approximately 11–14 months...
Cancer
Safety, Feasibility, and Effectiveness of Ketogenic Diet in Pediatric Patients with Brain Tumors: A Systematic Review

Researchers conducted a systematic review to assess the safety, feasibility, and potential effectiveness of a ketogenic diet in pediatric patients with brain tumors. The review included eight...
Cancer
Ketogenic metabolic therapy in conjunction with standard treatment for glioblastoma: a case report

Glioblastoma (GBM) is a highly aggressive brain tumor with a median survival rate of 12 to 15 months under standard care, which includes surgery, radiation,...